Gregory R. Gipson

449 total citations
17 papers, 308 citations indexed

About

Gregory R. Gipson is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Gregory R. Gipson has authored 17 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Immunology. Recurrent topics in Gregory R. Gipson's work include Inflammatory Bowel Disease (5 papers), TGF-β signaling in diseases (4 papers) and Immune Cell Function and Interaction (4 papers). Gregory R. Gipson is often cited by papers focused on Inflammatory Bowel Disease (5 papers), TGF-β signaling in diseases (4 papers) and Immune Cell Function and Interaction (4 papers). Gregory R. Gipson collaborates with scholars based in United States, Sweden and India. Gregory R. Gipson's co-authors include Shehzad Z. Sheikh, Hans Herfarth, Timothy S. Sadiq, Terrence S. Furey, Matthew Weiser, Thomas B. Thompson, R. Balfour Sartor, Chandramohan Kattamuri, Erin C. Steinbach and Jeremy M. Simon and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Gastroenterology.

In The Last Decade

Gregory R. Gipson

16 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory R. Gipson United States 8 137 119 87 48 42 17 308
Songchang Chen China 12 135 1.0× 108 0.9× 58 0.7× 50 1.0× 18 0.4× 51 356
Yosuke Shimodaira Japan 10 102 0.7× 108 0.9× 75 0.9× 50 1.0× 111 2.6× 39 368
Weigang Shu China 8 147 1.1× 103 0.9× 142 1.6× 23 0.5× 54 1.3× 10 366
Yoshiteru Murofushi Japan 10 176 1.3× 76 0.6× 78 0.9× 49 1.0× 32 0.8× 14 376
Konstantina Strongili United Kingdom 3 122 0.9× 95 0.8× 95 1.1× 72 1.5× 33 0.8× 4 276
Christopher Kingsley United States 10 184 1.3× 81 0.7× 41 0.5× 131 2.7× 24 0.6× 11 369
Nadim Hamzaoui France 8 88 0.6× 60 0.5× 61 0.7× 111 2.3× 88 2.1× 14 317
Yihan Xu China 12 176 1.3× 121 1.0× 104 1.2× 64 1.3× 62 1.5× 20 369
Yosra Thabet Tunisia 10 63 0.5× 99 0.8× 121 1.4× 34 0.7× 46 1.1× 12 343
Sebastian Hütker Germany 5 257 1.9× 56 0.5× 53 0.6× 57 1.2× 40 1.0× 6 387

Countries citing papers authored by Gregory R. Gipson

Since Specialization
Citations

This map shows the geographic impact of Gregory R. Gipson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory R. Gipson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory R. Gipson more than expected).

Fields of papers citing papers by Gregory R. Gipson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory R. Gipson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory R. Gipson. The network helps show where Gregory R. Gipson may publish in the future.

Co-authorship network of co-authors of Gregory R. Gipson

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory R. Gipson. A scholar is included among the top collaborators of Gregory R. Gipson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory R. Gipson. Gregory R. Gipson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ramachandran, Deepti, Gregory R. Gipson, Luca Troncone, et al.. (2025). Acute regulation of murine adipose tissue lipolysis and insulin resistance by the TGFβ superfamily protein GDF3. Nature Communications. 16(1). 4432–4432. 2 indexed citations
2.
Gipson, Gregory R., Kristof Nolan, Chandramohan Kattamuri, et al.. (2023). Formation and characterization of BMP2/GDF5 and BMP4/GDF5 heterodimers. BMC Biology. 21(1). 16–16. 3 indexed citations
3.
Briley, Shawn M., et al.. (2021). Deletion of Gremlin-2 alters estrous cyclicity and disrupts female fertility in mice. Biology of Reproduction. 105(5). 1205–1220. 10 indexed citations
4.
Goebel, Erich J., Chandramohan Kattamuri, Gregory R. Gipson, et al.. (2021). Structures of activin ligand traps using natural sets of type I and type II TGFβ receptors. iScience. 25(1). 103590–103590. 8 indexed citations
5.
Gipson, Gregory R., et al.. (2020). Structural perspective of BMP ligands and signaling. Bone. 140. 115549–115549. 41 indexed citations
6.
Weiser, Matthew, Reza Rahbar, Timothy S. Sadiq, et al.. (2020). Molecular classification of Crohn's disease reveals two clinically relevant subtypes. UNC Libraries. 3 indexed citations
7.
Gipson, Gregory R., Shehzad Z. Sheikh, & Erin C. Steinbach. (2020). Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice. UNC Libraries. 3 indexed citations
8.
Gipson, Gregory R., Chandramohan Kattamuri, Magdalena Czepnik, & Thomas B. Thompson. (2020). Characterization of the different oligomeric states of the DAN family antagonists SOSTDC1 and SOST. Biochemical Journal. 477(17). 3167–3182. 7 indexed citations
9.
Weiser, Matthew, Jeremy M. Simon, Bharati Kochar, et al.. (2016). Molecular classification of Crohn's disease reveals two clinically relevant subtypes. Gut. 67(1). 36–42. 89 indexed citations
10.
Simon, Jeremy M., James P. Davis, Matthew R. Schaner, et al.. (2016). Alterations to chromatin in intestinal macrophages link IL‐10 deficiency to inappropriate inflammatory responses. European Journal of Immunology. 46(8). 1912–1925. 26 indexed citations
11.
Weiser, Matthew, Shehzad Z. Sheikh, Bharati Kochar, et al.. (2016). O-004 Analysis of Chromatin and Transcriptional Profiles in Crohnʼs Disease Reveals Molecular Subclasses and Highlights Functional Regulatory Regions Implicated in Disease. Inflammatory Bowel Diseases. 22. S1–S2. 1 indexed citations
12.
Steinbach, Erin C., Gregory R. Gipson, & Shehzad Z. Sheikh. (2015). Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4<sup>+</sup>CD45RB<sup>high</sup> T Cells into Immunodeficient Mice. Journal of Visualized Experiments. 12 indexed citations
13.
Peck, Bailey C. E., Matthew Weiser, Gregory R. Gipson, et al.. (2015). MicroRNAs Classify Different Disease Behavior Phenotypes of Crohnʼs Disease and May Have Prognostic Utility. Inflammatory Bowel Diseases. 21(9). 2178–2187. 63 indexed citations
15.
Ulrich, Peter, Gregory R. Gipson, Martha A. Clark, et al.. (2014). In vitro and In vivo Antimalarial Activity of Amphiphilic Naphthothiazolium Salts with Amine-Bearing Side Chains. American Journal of Tropical Medicine and Hygiene. 91(4). 824–832. 1 indexed citations
16.
Steinbach, Erin C., Taku Kobayashi, Steven M. Russo, et al.. (2014). Innate PI3K p110δ Regulates Th1/Th17 Development and Microbiota-Dependent Colitis. The Journal of Immunology. 192(8). 3958–3968. 38 indexed citations
17.
Goldsmith, Jason R., Joshua M. Uronis, Gregory R. Gipson, & Christian Jobin. (2011). Mu Opioid Signaling and STAT3 Activation Protects Against Acute Murine Intestinal Injury in Mice. Gastroenterology. 140(5). S–654. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026